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ABSTRACT
The aim of this investigation was to evaluate whether there was a change in
pressure pain threshold (PPT) over the course of the menstrual cycle. Changes in PPT
were measured at 18 anatomical sites that are used in the diagnosis of fibromyalgia.
Hypothetically, cyclical changes in PPT at these sites may influence the diagnosis of
fibromyalgia. PPTs were assessed over two menstrual cycles using 11 normally
menstruating women. PPTs were recorded at three different experimental sessions
performed during the menstrual phase (approximately day 3 of menstrual cycle), the
follicular phase (approximately day 12-13 of menstrual cycle) and the luteal phase
(approximately day 21 of menstrual cycle). A hand-held spring algometer was used to
apply pressure to the 18 anatomical sites. An effect size of 0.2 showed small
differences between the menstrual and luteal phases in both cycles tested. The
menstrual phase showed the lowest mean (standard deviation) PPT in month one and
two of 3.15 kg (1.05) and 3.59 kg (1.0) respectively. The luteal phase showed the
highest mean (standard deviation) PPT in consecutive cycles of 3.39 kg (1.07) and 3.72
kg (0.8) respectively. There was a general trend of increasing PPT over the six
experimental sessions which is hypothesised to be a result of habituation to the
experimental stimulus. The greatest variability was found when comparing the nine
anatomical sites where pressure was applied. In these locations most comparisons
showed large effect sizes. The PPTs found in the current study show individual
variation within and between menstrual cycles, which may impact on the individual
diagnosis of fibromyalgia.
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1INTRODUCTION
There are many factors that could potentially influence a woman’s sensitivity to
pain. One such factor may be hormonal fluctuations that occur during the menstrual
cycle. The potential effect of hormonal changes on pressure and pain sensitivity has
particular relevance to the practice of osteopathy. The techniques used by an osteopath
often induce pressure on body tissues and may generate pain. The female patient may
be more sensitive to pressure and pain at certain times of the menstrual cycle. If so this
variation in pain sensitivity should be considered in both the formulation of a treatment
plan and in the techniques used during treatment.
One of the earliest studies to examine the effect of the menstrual cycle on the
perception of experimentally induced pain was in 1933 (Riley, Robinson, Wise, &
Price, 1999). Since then it has been established that there are changes in pain thresholds
due to hormonal fluctuations during the menstrual cycle. However, more research in
this area is needed in order to establish if there is a regular, reproducible pattern of
change in pain thresholds due to fluctuations of various hormones. At present a
reproducible pattern has not been found. There is conflicting evidence in the literature
regarding which phase of the menstrual cycle results in the lowest pain threshold and
which results in the highest pain threshold. The PPT is the moment at which the
stimulus becomes painful. The results of some studies are in agreement with each other.
For example, Hapidou and Rollman (1998) found that women had fewer tender sites in
the luteal phase. This finding agrees with a study that reported that the highest pain
threshold was measured in the luteal phase (Giamberardino, Berkley, Iezzi,
deBigontina, & Vecchiet, 1997). The results of other studies conflict with each other.
For example, Drobek, Schoenaers, and DeLaat, (2002) found that the highest pressure
pain threshold (PPT) was in the menstrual phase, while Bajaj, Arendt-Nielsen, Bajaj,
and Madsen, (2001) found the opposite result that the lowest PPT was in the menstrual
phase.
In this investigation of changes in PPT over the course of the menstrual cycle,
healthy female participants were tested. PPT is defined as the minimum pressure which
induces pain or discomfort (Fischer, 1987). The testing was performed over the time
period of two menstrual cycles. The aim of this research was to begin an ongoing
investigation into the changes in PPT due to hormonal fluctuations during the menstrual
cycle. This study examined whether potential changes in the first menstrual cycle tested
2were reproduced in the second cycle, and if the changes corresponded to fluctuations of
particular hormones.
3LITERATURE REVIEW
It is clear from the literature surrounding this topic that there are variations in
many areas of pain threshold investigation. There is a diversity of methodology used to
investigate the effect of natural hormonal fluctuations on pain threshold. This diversity
includes the operational definitions used for the phases of the menstrual cycle, methods
used to apply experimental stimulation and the anatomical sites tested. These topics are
discussed along with the variables that can influence the experimental measurement of
pain and the 18 anatomical sites used in the diagnosis of fibromyalgia, as these are the
sites at which pressure was applied in the current study.
Diversity of Methodology
In the current study it was necessary to determine which days of the menstrual
cycle correspond to each phase of the menstrual cycle. It is widely accepted that the
menstrual cycle consists of events occurring in the ovaries (the ovarian cycle) and
events occurring in the uterus (the uterine cycle). The ovarian cycle consists of the
follicular phase (pre-ovulation) and the luteal phase (post-ovulation). The uterine cycle
consists of the menstrual phase (menses), the proliferative phase (pre-ovulation) and the
secretory phase (post-ovulation). Ovarian changes that occur during the menstrual cycle
depend completely on the gonadotrophic hormones, follicle stimulating hormone (FSH)
and luteinizing hormone (LH). During the follicular phase FSH is secreted by the
anterior pituitary gland. In this phase there is accelerated growth of the primary
follicles each month. About two days before ovulation the secretion of LH from the
anterior pituitary increases markedly and peaks 16 hours before ovulation. FSH
secretion also increases at this time but not to the extent of LH. It is widely accepted
that ovulation occurs approximately 14 days after the onset of menstruation. The luteal
phase involves the formation of the corpus luteum after ovulation. The corpus luteum
produces large amounts of progesterone and oestrogen, this production is stimulated by
FSH and LH.
The menstrual cycle averages 28 days in duration. The length can range from
25-30 days (Riley et al., 1999). The interval from the onset of menses to ovulation (the
follicular phase) is the most variable in duration and accounts for the range of cycle
lengths observed in ovulating women. The interval from ovulation to the onset of
menstrual bleeding (the luteal phase) is relatively constant (Riley et al., 1999).
4Discrepancies between studies of menstrual cycle modulation of pain may be
due to different procedures used in phase calculations (Hapidou & Rollman, 1998).
Different studies provide different definitions of the days that correspond to each phase
(Figure 2.1). Some studies provide similar but not exact definitions. For example, in
one study comparing the pain thresholds for electrical stimuli, the menstrual cycle was
divided into four phases (Giamberardino et al., 1997). The first day of the menstrual
cycle was counted as day zero, days 2-6 were defined as the menstrual phase, days 12-
16 the periovulatory phase, days 17-22 as the luteal phase and days 25-28 as the
premenstrual phase. This definition is very similar to two studies investigating sensory
changes during the menstrual cycle (Bajaj et al., 2001; Bajaj, Bajaj, Madsen, & Arendt-
Nielsen, 2002). The differences were that Giamberardino et al. (1997) counted the first
day of the menstrual cycle as day zero where Bajaj et al. (2001) and Bajaj et al. (2002)
counted it as day one. The menstrual phase was defined by Giamberardino et al. (1997)
as days 2-6, whereas Bajaj et al. (2001) and Bajaj et al. (2002) defined it as days 1-6.
The wording used for days 12-16 was slightly different between the two studies,
Giamberardino et al. (1997) called it the periovulatory phase and the other two studies
called it the ovulatory phase. There was some agreement between the results of Bajaj et
al. (2002) and Giamberardino et al. (1997), the former study reported the lowest PPT of
women with dysmenorrhoea to be in the menstrual phase and the latter study reported
the lowest pain threshold to be in the perimenstrual phase. This agreement may be due
to the fact that the perimenstrual phase defined by Giamberardino et al. (1997) included
the days of the menstrual phase defined by Bajaj et al. (2002).
Most of the previous studies investigating PPT used a retrospective method to
decide in exactly what phase of the menstrual cycle the experimental session was
performed (Bajaj et al., 2001; Bajaj et al., 2002; Drobek et al., 2002; Giamberardino et
al., 1997; Hapidou & Rollman, 1998). This retrospective method could lead to a
substantial difference in the phase of the menstrual cycle that each participant was
tested in, producing inconsistent and inconclusive results. Hapidou and Rollman (1998)
were the only researchers to include all 28 days of the menstrual cycle in their definition
of the phases of the menstrual cycle. Other studies left days unaccounted for which
could pose a problem if, on retrospective analysis it was found that experimental testing
took place on a day that was not included in the operational definition of each phase.
Inconsistencies in assigning days to phases have been worsened by the use of
different terms by different researchers. For example the follicular phase of the ovarian
5cycle corresponds with the menstrual and proliferative phase of the uterine cycle, and
can also be called the preovulatory phase in relation to when ovulation occurs. Most of
the studies use a combination of the ovarian cycle and the uterine cycle in their
definition of phases.
Direct comparisons cannot be made between the results of different studies if
experimental testing is performed at different stages of the menstrual cycle. In the
current study prospective analysis was used in order to schedule experimental testing
times at specific stages of the menstrual cycle, rather than retrospectively assessing
when the experimental sessions took place.
Another area of discrepancy in methodology was the variety of stimulation
modalities that have been used to induce pain. The methods used include muscle
ischemia, electrical current, thermal heat, pressure stimulation and strain-gauge.
Different physiological pathways are activated depending on the type of external
stimulation. For example heat and mechanical stimulation activate a different
neurological pathway to that activated by electrical stimulation (Gibson & Helme,
2001). Therefore the impact of the menstrual cycle on pain sensitivity may be different
for different types of stimulation. The tissue depth being stimulated will vary
depending on the method and may also contribute to inconsistencies between studies
(Giamberardino et al., 1997).
The anatomical site at which the experimental stimulus was applied is another
variable preventing direct comparison of studies. Isselee, DeLaat, Bogaerts and Lysens
(2001) and Drobek et al. (2002) were interested in the change in PPT of masticatory
muscles; they tested the masseter and temporalis muscles on both sides and used the
first dorsal interosseous muscle as a control site. Bajaj et al. (2001) and Bajaj et al.
(2002) used two areas they considered to be sites of referred menstrual pain, which were
on the abdomen at the level of the 10th to 12th thoracic vertebrae and the low back at the
level of the 2nd to 4th sacral vertebrae. They also used two sites outside the area of
referred menstrual pain on the arm and the thigh. Hapidou and Rollman (1998) used 13
sites bilaterally; seven of these were included on the list of Diagnostic Criteria for
Fibromyalgia Syndrome (Wolfe et al., 1990). Three sites were chosen based on areas
that were considered tender in other studies, and three were control sites, at the forearm,
thumbnail and mid-foot.
6This variation in methodology makes it impossible to directly compare studies
investigating the same topic because different methods may lead to differences in
results. The specific areas of significance that have been inconsistent in previous
research are the definition of the phases of the menstrual cycle, the method of
experimental stimulation and the sites at which this stimulus is applied.
Experimental Measurement of Pain
This research project involved the assessment of pain. When investigating
experimentally induced pain many factors can influence the participant’s response to the
stimulus. These factors need to be kept in mind and controlled as much as possible in
order to achieve consistent, reliable and ethical results.
The change in PPT could not be investigated without asking each participant to
verbally indicate when pressure applied to a particular site changed from a sensation of
pressure to a sensation of pain. Therefore the results are based on subjective
information. The subjective nature of the current study could have allowed for a huge
variation in responses. One person’s idea of what is painful may be quite different to
another’s. Gender, age, and cultural beliefs all have an effect on how a person
expresses pain and when they will report a sensation as being painful. It is now
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Figure 2.1: A schematic representation of the phases of the menstrual cycle defined by different researchers.
1) Hapidou and Rollman (1998). 2) Amodei and Nelson-Grey (1988). 3) Drobek et al. (2002). 4) Bajaj et al.
(2001) and Bajaj et al. (2002). 5) Giamberardino et al. (1997). 6) Isselee et al. (2001).
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7recognized that the human pain experience is not solely due to sensory or nociceptive
events but involves a complex interaction of sensory, cognitive, and behavioural
processes (Melzak & Wall, 1965).
The body’s system for detecting pain is not fixed and predictable as was once
thought. The nociceptive system has the capacity to modify its response to the same
amount of tissue damage using diverse physical and psychological factors. This means
that an individual’s pain can not be predicted solely by the nature of the tissue damage.
Although it is likely that most people attempt to honestly report their subjective pain
experience, what people tell us about pain experience is altered by their own personal
experience and beliefs, therefore people experiencing the same amount of pain will
respond differently (Turk & Melzack, 1992).
Gender difference may cause variations in pain expression. Levine and
DeSimone (1991) investigated gender role expectations in the reporting of pain. Males
holding their hand in iced water in the presence of an attractive female reported less
pain than when in the presence of another male. Female participants were not
significantly influenced by the gender of the experimenter (Levine & DeSimone, 1991).
An investigation was conducted into gender differences in PPT (Chesterton, Barlas,
Foster, Baxter, & Wright, 2003). In this study pressure was applied to the first dorsal
interosseous muscle using a pressure algometer. Healthy females exhibited a
significantly lower mean PPT in the first dorsal interosseous muscle than healthy males,
this result was maintained for fourteen repeated measures within a one hour period
(Chesterton et al., 2003). These examples demonstrate the differences found between
male and female participants in experimental situations. In the current study there were
only female participants, however the gender differences help to illustrate the point that
there are many things influencing the reporting of pain in experimental situations. The
results also highlight the importance of keeping the experimental conditions, such as the
person carrying out the experiment, consistent throughout the trial in order to avoid bias
in reporting pain.
Age is another influence on the reporting of experimental pain. Gagliese, Katz
and Melzack (1997) have shown that age difference in pain ratings may depend on the
pain assessment scale used for measurement. A sample of 79 patients with chronic
arthritis showed an age-related decrease in the sensory (physical sensation) and
affective (emotional interpretation) dimensions of pain using the short form McGill Pain
Questionnaire, but no age difference in pain intensity as measured by a Visual Analogue
8Scale or a Verbal Descriptor Scale (Gagliese et al., 1997). Studies using a mechanical
form of stimulation support the notion of age differences in pain thresholds. Five of six
studies reviewed by Gibson and Helme (2001) noted increased pain thresholds in adults
of advanced age. In a study of 704 participants, PPT was shown to increase by about
15% in older adults, the effect was stronger in female participants (Gibson & Helme,
2001). The age of the ‘older adults’ was not specified in this article. In contrast to these
results, studies using electrical stimulation suggest there are no age differences in pain
threshold (Gibson & Helme, 2001). The different results may be due to differences in
the mechanism of pain activation. Electrical stimulation activates primary afferent
fibres directly, whereas heat and mechanical stimulation require mechanisms of receptor
activation and energy transduction to stimulate sensory fibres (Gibson & Helme, 2001).
Age-related change in receptor morphology and function could be used to explain the
altered mechanical pain perception in the absence of altered electrical pain thresholds.
Changes in the skin are also important factors, the thinning of the epidermis, reduction
in elasticity and flattening and separation of dermal-epidermal junction may effect the
energy transduction process (Gibson & Helme, 2001). According to Turk and Melzack
(1992), older age may be associated with a decrease in nociceptor density. This
decrease in density could produce a decrease in sensitivity to noxious stimuli with
increasing age, but no convincing evidence exists. Although there is some evidence of
an age-related decrease in the intensity of musculoskeletal pain, further investigation is
required (Gagliese et al., 1997).
Another important factor is response bias differences in labelling events as
‘pain’. Elevated pain threshold in an older adult compared with a young individual may
reflect a bias against reporting an event as painful. The intention of the participant to
help the experimenter may lead to artificially elevated pain thresholds (Turk &
Melzack, 1992). In the current study there was a limited age range specified, one of the
inclusion criteria is that participants must be between the ages of 18-35 years. Studies
comparing differences in pain threshold with age usually specify groups below 60 years
and over 60 years, in such studies the participants aged 18-35 would all be considered in
the same age group. Using a narrow age range in the current study was intended to
prevent variation in the reporting of pain due to differences in age.
There are certain influences that govern the way in which emotion is expressed.
People usually conform to what they have been taught to be socially acceptable leading
to cross-cultural variation in the display of emotion and pain (Turk & Melzack, 1992).
9People learn in social communities, where conventional ways of interpreting, expressing
and responding to pain are acquired (Bates, Edwards, & Anderson, 1993). Culturally
acquired patterns may influence the processing of nociceptive information as well as
psychological, behavioural, and verbal responses to pain (Bates et al., 1993). Several
studies of experimental and acute pain have found that cultural or ethnic background is
associated with significant variation in pain intensity reports as well as attitudes,
emotions and behaviours associated with pain. Bates et al. (1993) conducted a study to
examine the influence of cultural variables on chronic pain perception. It was found
that there were significant differences in the attitudes toward chronic pain and in the
behavioural, psychological and emotional responses to chronic pain. The six largest
ethnic/cultural groups in the study area (Worcester, Massachusetts, USA) were used.
The first group comprised of ‘Old Americans’. These people identified with no ethnic
group but defined themselves as Americans. The other groups were Hispanics, Irish,
Italians, French Canadians and Polish. The group with the highest pain intensity rating
(lowest tolerance for pain) was the Hispanic group, followed by the Italian group. The
Polish and French Canadian groups had the lowest pain intensity rating. Members of
the Hispanic group believed most strongly that as long as they had pain, their lives
would remain unhappy. They reported their pain more frequently and emotionally and
had significantly higher degrees of anger, worries and tension associated with their pain.
Many members of the Hispanic and Italian groups indicated a belief that emotional
expression was an appropriate response to pain, while members of the Old American
and Polish groups generally indicated that non-expression of pain was the ideal
response. This study found differences in the accepted standards for and attitudes
towards pain and pain behaviour within defined ethnic groups. The study suggests that
cultural back-ground is significantly related not only to differences in reported pain
perception but also to total pain intensity and the description of pain. The association
between pain intensity and ethnic identity suggests that experiences, beliefs, attitudes
and meanings derived from growing up within these social communities may affect
one’s reported perception of pain intensity .
In order to attain a homogenous sample in the current study, only New Zealand
European females were included. Each participant acted as her own control; the results
of each participant were compared over time. This method of evaluation was intended
to help to reduce the influence of external factors such as age and culture. The
individual was expected to report the onset of pain consistently, based on the same
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understanding of what pain is and what is culturally acceptable, in each experimental
session.
Anatomical Sites Used in the Diagnosis of Fibromyalgia
In the current study pressure was applied at the 18 anatomical sites used in the
diagnosis of fibromyalgia. The understanding of fibromyalgia has changed over the
years and the criteria for establishing a diagnosis of fibromyalgia has undergone a
process of evolution from the 1940s when fibromyalgia was a term that was applied to a
diverse series of musculoskeletal complaints such as strains, bursitis and psychogenic
rheumatism (Wolfe, 1986).
A standard diagnostic criteria was developed by a committee of health
professionals who set out in an effort to provide a widely accepted definition for
fibromyalgia (Wolfe et al., 1990). This new investigation was done based on the fact
that a number of criteria sets had already been established, but were based on studies
with serious methodological problems (Wolfe et al., 1990). In this study tender sites
were found to be the most powerful discriminator between fibromyalgia patients and
controls. Widespread pain had a sensitivity of 97.6%. The best criteria were identified
when wide spread pain was combined with the presence of 11 out of 18 tender sites,
which was the variable that had the best overall sensitivity, specificity, and accuracy
(Wolfe et al., 1990).
The tender point sites selected by the committee for use with the 1990 criteria
were chosen based on those used in other criteria sets. Three lower-segment sites
(buttocks, trochanters, knees) were included to emphasise the widespread nature of the
tenderness and to avoid false-positive results in patients with shoulder girdle pain and
similar syndromes (Wolfe et al., 1990). Six sites (three pairs) were eliminated due to
low discriminatory power. This left 18 of the original sites of tender point examination
in the final diagnostic criteria. The sites on the upper part of the body were the occiput
at the suboccipital muscle insertions, low cervical at the anterior aspects of the
intertransverse spaces at C5-C7, the trapezius muscle at the midpoint of the upper
boarder, the supraspinatus muscle at the origin above the spine of the scapular near the
medial boarder, the second rib at the second costochondral junction and the lateral
epicondyle of the humerus 2cm distal to the epicondyle. The sites on the lower half of
the body were the gluteal region at the upper outer quadrant of the buttock, the greater
trochanter, just posterior to the trochanteric prominence and the knee, on the medial fat
pad proximal to the joint line, these sites are all tested bilaterally (Wolfe et al., 1990).
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The onset of fibromyalgia often occurs when the levels of oestrogen and
progesterone are changing, around the times of menarche, childbirth and perimenopause
(Anderberg, Marteinsdottir, Hallman, & Backstrom, 1998). This pattern indicates that
gonadal hormones may play a role in the development of fibromyalgia (Anderberg et
al., 1998). A study was conducted to investigate the effects of hormonal changes during
the menstrual cycle on the psychological and physical symptoms of fibromyalgia. It
was found that of all the symptoms recorded, pain scored the highest as the most
adverse symptom. Patients suffering from fibromyalgia reported more pain in the
perimenstrual phase compared to the ovulatory phase. The study reported that
hormonal changes in the luteal phase, especially perimenstrually, aggravate the pain of
fibromyalgia syndrome (Anderberg et al., 1998). The study had a small sample size, 16
patients diagnosed with fibromyalgia and 15 healthy control participants, which limits
the generalizability of the results, however it demonstrates the influence of gonadal
steroids on the symptoms of fibromyalgia and on healthy control participants
(Anderberg et al., 1998).
In the current study it was decided to use the 18 anatomical sites used in the
diagnosis of fibromyalgia because they are wide-spread and have the potential to
demonstrate a systemic effect of hormonal changes on pain threshold. It was also
thought that the results of the current study might indicate if change in PPT due to
hormonal fluctuations during the menstrual cycle might affect the diagnosis of
fibromyalgia.
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METHODOLOGY
The current study was designed to determine the extent to which PPT fluctuated
over the course of the menstrual cycle and to show if any fluctuation in PPT was
consistent and reproducible form one cycle to the next. A prospective, repeated-
measures analysis of variance design was used. The PPT was measured repeatedly
(three times) over the course of one menstrual cycle and repeated in a second menstrual
cycle. The difference between the PPT at the three different experimental sessions was
analysed. The analysis was of an individual’s results over time therefore participants
acted as their own controls. All participants received the same treatment.
Participants
Following approval from Unitec Research Ethics committee (see Appendix A)
female student volunteers were recruited from Unitec New Zealand. Notices were
posted on notice boards around the campus (see Appendix B), on the Unitec
Blackboard™ web site and announcements were made at the beginning of lecture
sessions. Snowball sampling, a type of convenience sampling, was used (Polit &
Hungler, 1997). Recruited participants were asked to identify and refer other people
who met the eligibility criteria for the study.
Inclusion Criteria
To be included in this study there were several criteria that had to be met:
• Participants were required to be between 18 and 35 years of age. This age range
was chosen to insure that those included in the study had established regular
menses and exclude women who were beginning menopause. The age range
was kept small in order to select a more homogenous sample.
• Participants were required to have histories of regular, predictable menstrual
cycle lengths of 25-30 days. To ensure this regularity participant’s menstrual
cycles were recorded by the researcher on notification by participants.
Recording was carried out for two months (two menstrual cycles) after
enrolment and before the commencement of the experimental sessions. This
information was then used to schedule each participant individually for
experimental sessions.
• Participants were required to be of New Zealand European ethnicity. This
requirement was based on the strong prevalence of European usage of
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osteopathy (Moore, 2003), and the importance of obtaining a homogeneous
sample.
Exclusion Criteria
Exclusion from this study was based on factors that could alter a women’s
sensitivity to pressure or change the normal fluctuation of female sex hormones.
Those excluded were:
• Women suffering from dysmenorrhoea or any other general health problem that
may alter the PPT.
• Women taking oral contraceptives or receiving intramuscular injections for birth
control as synthetic hormones alter the natural fluctuation of female sex
hormones (Guyton & Hall, 2000).
• Women having a clinical history of major psychological problems, or taking
medication for psychological problems. It has been shown that people suffering
from high levels of psychological distress and high scores on depression scales
had associated low pain thresholds (Chiu et al., 2005).
• Women with a diagnosis of fibromyalgia, rheumatological disease or chronic
pain syndrome as these conditions have been shown to alter pain thresholds
(Hendiani et al., 2003; Laursen, Bajaj, Olsen, Delmar, & Arendt-Nielsen, 2005).
Before enrolment for this study participants were asked to complete an
information sheet relating to their general health at the present time and relevant
medical history (Appendix C). This information was necessary in order to screen for
factors that may affect the results of the study. Once enrolled, participants answered
follow up questions before each experimental session to ensure there were no major
changes in their health status over the course of the study (Appendix D).
Following consent procedures (Appendix E and F), participants were given a
training session to acquaint them with the sensations evoked by the experimental
stimuli. Participants were requested where possible to abstain from using analgesics
during the two-month experimental period. Participants were asked before each
experimental session if they had taken any analgesics in the previous two or three days,
if they had had any changes in health status. Anything reported by participants was
recorded (see page 19). 
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Testing Protocol
Participants were asked to attend experimental sessions six times in total, over a
two month period. Sessions were held at the Unitec Osteopathic Clinic.
Experimental session scheduling
In the current study a prospective method was used to schedule participants for
their experimental sessions. Each participant reported the first and last day of menses to
the researcher for two menstrual cycles before the commencement of experimental
sessions. The researcher then ensured that each participant’s cycle length was
consistently 25 to 30 days in length. Experimental sessions began in the third menstrual
cycle. The researcher used the date of the first day of each participant’s third menses as
day one. Each participant was scheduled for three experimental sessions per menstrual
cycle, on approximately the 3rd, 12th or 13th and 21st days of the menstrual cycle. The
3rd day of the menstrual cycle was chosen because it is widely reported to correspond
with low levels of the hormones oestrogen and progesterone. At this time levels of
follicle stimulating hormone (FSH) and luteinizing hormone (LH) are beginning to
increase. The 12th to 13th day of the menstrual cycle is the time at which secretion of
oestrogen is at its highest. At this point LH and FSH secretion is also increasing. The
21st day of the menstrual cycle is approximately midway through the luteal phase of the
menstrual cycle and is the stage of the cycle when progesterone secretion is at its
highest point. At this stage LH and FSH are at very low levels of secretion. The
scheduling of these three experimental sessions was repeated in the second month of
experimental testing, assessing changes in PPT with respect to fluctuations of these four
key hormones.
Sites where pressure was applied
In the current study, nine anatomical sites used in the diagnosis of fibromyalgia
were assessed (Wolfe et al., 1990). Each site was bilateral (left and right sides),
providing a total of 18 sites to measure PPT all over the body (Wolfe et al., 1990).
1. Low cervical: at the anterior aspects of the intertransverse spaces at C5-7.
2. Second rib: at the second costochondral junctions, just lateral to the
junctions on upper surfaces.
3. Lateral epicondyle of humerus: 2cm distal to the epicondyle.
4. Knee: at the medial fat pad, proximal to the joint line.
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5. Occiput: at the suboccipital muscle insertions.
6. Trapezius muscle: at the midpoint of the upper boarder of the muscle.
7. Supraspinatus muscle: at origins, above the spine of the scapula near the medial
border.
8. Gluteal: in upper outer quadrants of buttocks in anterior fold of
muscle.
9. Greater trochanter: posterior to the trochanteric prominence.
Equipment
A spring algometer was used (Activator Methods Instruments, Melbourne) to
apply pressure to the anatomical sites. The algometer consists of a force dial which
reads in pounds and kilograms and a metal rod with a 1cm diameter rubber tip at the
end. Pressure exerted on the rod is transmitted to the body of the algometer and moves
the indicator needle in a clockwise direction. The indicator needle remains at the
achieved force value until the zeroing knob is pressed.
Procedure
Participants were required to wear shorts and a singlet and to lie comfortably on
a treatment table during each experimental session. Each experimental session took
approximately fifteen minutes. The amount of force required to change the sensation of
local pressure to the onset of local pain was measured. Experimental sessions
proceeded in the following way:
1. Participants were given instructions to say “pain” as soon as the sensation of
pressure changed to a sensation of pain.
2. Participants were required to lie on their backs (supine) for the first eight sites
and on their fronts (prone) for the last ten sites.
3. Each site was located by palpation using anatomical landmarks.
4. The algometer was held in the palm of the researcher’s hand between the thumb
and index finger. The algometer was positioned perpendicular to the
participant’s skin with the rubber tip over the anatomical site.
5. Before applying pressure on each site the researcher would say “applying now”
and then begin applying pressure. The algometer was advanced at a steady rate
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of 1kg per second (Fischer, 1987). The anatomical site on the left side of the
participant was tested first, followed by the corresponding right sided site.
Anatomical sites were tested in the order they are described above.
6. When the participant indicated the PPT by saying “pain” the algometer was
immediately removed.
7. The reading on the force dial was recorded in kilograms.
8. The needle of the gauge was reset by pressing the pressure release button before
the next reading was taken.
Data Management
All the raw data collected during experimental sessions were typed into a
Microsoft Excel® spreadsheet, which resulted in eleven sets of data, one set per
participant. Each set consisted of PPTs recorded in kilograms. Nine anatomical sites
were tested on the left and right leaving 18 values for each participant in each test. Each
participant underwent six test sessions. Tests one, two and three were performed in the
first menstrual cycle and tests four, five and six were performed in the second menstrual
cycle. Tests one and four were performed in the menstrual phase of the menstrual
cycle, tests two and five were performed in the follicular phase of the menstrual cycle,
and tests three and six were performed in the luteal phase of the menstrual cycle.
Prior to statistical analysis, data were arranged in three different ways. The first
data arrangement compared the differences in PPT measurements over time, within each
menstrual cycle and between each menstrual cycle. The second was to compare PPT
measurements at left versus right anatomical sites, and the third was to compare the nine
different anatomical sites.
The mean PPT for the 18 anatomical sites in each of the six test sessions was
calculated for all 11 participants. These means were used to compare tests one and two,
tests one and three and tests two and three in the first menstrual cycle, and tests four and
five, tests four and six, and tests five and six in the second menstrual cycle. The
comparison between menstrual cycles was investigated using the same test sessions in
consecutive menstrual cycles. Thus, test one was compared with test four, test two with
test five and test three with test six.
Secondly data were arranged in order to compare PPT measurements on the left
and right sides of the body. All the data recorded from testing anatomical sites on the
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left were separated from the data recorded from testing anatomical sites on the right.
The mean of the nine sites on the left was taken for each of the six test sessions, for each
of the 11 participants; the same was done for the sites on the right. This approach
resulted in one mean for each test on the left and each test on the right, for each
participant, in each of the six tests. The means of test one on the left were compared to
the means of test one on the right.
Thirdly data were arranged in order to compare PPT measurements at the nine
different anatomical sites. The first four sites were anterior; these were at the
intertransverse spaces at the level of the 5th to 7th cervical vertebra, the costochondral
junction of the second ribs, the lateral epicondyle of humerus, and the medial fat pad of
the knee. The next five sites were posterior; on the suboccipital muscle insertions, over
the middle fibres of the trapezius muscle, at the origin of the supraspinatus muscle, on
the boarder of the gluteal muscles, and over the greater trochanteric prominence. Each
anatomical site was tested six times over two menstrual cycles. Eleven participants
were tested left and right resulting in 22 PPTs recorded during each of the six testing
sessions for each of the anatomical sites. The mean PPT of the left and right anatomical
sites was calculated for each participant at each of the six test sessions. This calculation
was done for each of the nine anatomical sites. This approach resulted in 11 means at
each anatomical site for each of the six testing sessions. Next the mean of all 11
participants PPT was calculated at each anatomical site. The tests were then separated
into menstrual cycles. Tests one, two and three were performed in the first menstrual
cycle and tests four, five and six were performed in the second menstrual cycle.
Previous analysis (Table 4.1) showed only a trivial or small difference between each of
the three test sessions in each menstrual cycle. Based on this finding it was decided to
group the three test sessions from cycle one together and the three test sessions from
cycle two together for future analysis. Menstrual cycle one then had three means for
each anatomical site, as did menstrual cycle two. Exactly the same analysis was
performed on the data from each menstrual cycle, however they were treated
individually. The resulting three means of anatomical site one were compared to those
of anatomical site two, site one was then compared to site three, then four and so on to
nine. Site two was then compared to each of the other eight anatomical sites as were
three, four, five, six, seven, eight and nine.
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Statistical Analysis
Data were analysed using a repeated-measures analysis of variance design. The
individual participants PPT measurements were compared over six experimental
sessions using the change scores between tests. Intra-class correlation coefficients and
95% confidence intervals were used to examine the relationship between the same
participant’s results at different experimental testing times. This procedure enabled an
estimate of the magnitude of change in individual participants score over the course of
the menstrual cycle.
Differences between corresponding test sessions in the two menstrual cycles and
different test sessions within the same menstrual cycle were computed as raw (kg) force
values and effect sizes. Precision of the estimates was calculated using 95% confidence
intervals. Confidence limits were not adjusted to hold the overall Type O error rate to
5% (the chance that any true value in this study falls outside its confidence interval;
Hopkins, 1997). The author is of the opinion that in publishing precision of estimates,
controlling error rate is not an issue. Readers should interpret reported effects by
acknowledging that the population value may be outside the confidence interval for
some of the effects. In instances where differences in means were represented as
multiples of standard deviations, the magnitudes of the effects were interpreted
according to the criteria of Cohen, (1988) and Hopkins, (1997): trivial, 0.0; small, 0.2;
moderate, 0.6; and large, 1.2.
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RESULTS
Participants
Twelve women met the inclusion criteria and were recruited. One of the
participants withdrew from the study before the experimental sessions began. The age
of the remaining eleven participants ranged from 19 to 35 years with a mean of 26
years. Nine of the participants were osteopathy students and two were nursing students.
One participant took the morning-after pill in the time between the fifth and sixth test
sessions. Data analysis (an example of some of the analysis can be found in Appendix
G) with and without her results showed very little difference therefore it was decided to
include her data in all statistical analysis. One participant was taking oral progesterone
supplements. It was decided to include this participant in the study because the
synthetic hormones were designed to maintain her progesterone levels at normal
concentrations.
Comparison of the Three PPT Measurement sessions within
Each Menstrual Cycle
Differences between mean PPTs for all participants recorded in the first and
second months were found to be trivial or small. These differences expressed as effect
sizes are given in Table 4.1.
Table 4.1: Intra-cycle Test Point Comparisons
Comparison Effect Size Lower 95%
Confidence Limit
Upper 95%
Confidence Limit
Interpretation
Test 1 & 2 0.1 -0.8 1.1 Trivial
Test 1& 3 0.2 -0.7 1.2 Small
Test 2 & 3 0.1 -0.8 1.1 Trivial
Test 4 & 5 0.02 -1.0 1.0 Trivial
Test 4 & 6 0.2 -0.8 1.1 Small
Test 5 & 6 0.1 -0.8 1.1 Trivial
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Comparison of PPT Measurements during the same Phase of
the Menstrual Cycle in Consecutive Months
Analysis was performed to determine the degree to which the PPT
measurements varied between test sessions during the same phase of the menstrual
cycle in two consecutive months. Effect statistics in raw kg values were calculated and
can be found in Table 4.2, mean PPT values are shown in Figure 4.1.
Table 4.2: Inter-cycle Test Point Comparisons
Comparison Effect Statistic (kg) Lower (95%)
confidence limit
Upper (95%)
confidence limit
Test 1 & 4 0.4 -0.5 1.4
Test 2 & 5 0.3 -0.6 1.3
Test 3 & 6 0.3 -0.5 1.2
Effect sizes were also calculated and showed a small difference in all three
comparisons. The estimated value of the difference between tests one and four was 0.4
(likely range -0.5 to 1.3). The difference between tests two and five, and tests three and
six both had an effect size of 0.4 (likely range of -0.6 to 1.3).
A raw change score was calculated to find the degree of variation in the change
in PPT between tests one and two, tests two and three and tests one and three in
consecutive months. The results are shown in Table 4.3.
Table 4.3: Comparison of Change Scores between Pairs of Tests in Consecutive
Months
Comparison Effect statistic (kg) Lower (95%)
confidence limit
Upper (95%)
confidence limit
Test 1& 2 v test 4 & 5 0.1 -0.1 0.3
Test 2 &3 v test 5 & 6 0.1 -0.1 0.3
Test 1 &3 v test 4 & 6 0.2 -0.2 0.6
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Figure 4.1: Pressure pain thresholds measured at all anatomical sites in all participants
partitioned into six test sessions
Comparison of PPT at Left and Right Anatomical Sites
Analysis was performed to compare left and right anatomical sites in each of the
six tests session. This resulted in raw (kg) force values that showed very small
differences between left and right anatomical sites (Table 4.4). Raw force values are
illustrated in Figure 4.2. Effect sizes (Table 4.5) showed trivial differences between
PPT recorded on left and right sides of the body.
Table 4.4: Raw values of comparison between pressure pain threshold at left and right
anatomical sites
Comparison Effect Statistic (kg) Lower 95%
confidence limit
Upper 95%
confidence limit
Test 1 left v right 0.07 -1.0 1.2
Test 2 left v right 0.06 -1.0 1.1
Test 3 left v right 0.03 -1.0 1.1
Test 4 left v right 0.06 -0.9 1.0
Test 5 left v right 0.1 -0.4 0.5
Test 6 left v right 0.06 -0.7 0.9
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Table 4.5: Effect sizes of the comparison between pressure pain threshold at left and
right anatomical sites
Comparison Effect Size Lower 95%
confidence limit
Upper 95%
confidence limit
Interpretation
Test 1 left v right 0.07 -0.9 1.0 Trivial
Test 2 left v right 0.05 -0.8 0.9 Trivial
Test 3 left v right 0.03 -1.0 1.1 Trivial
Test 4 left v right 0.06 -0.9 1.0 Trivial
Test 5 left v right 0.1 -0.4 0.5 Trivial
Test 6 left v right 0.08 -1.2 1.3 Trivial
Figure 4.2: Comparison of pressure pain thresholds on left and right sides of the body
Comparison of PPT measurements at Different Anatomical
Sites
Menstrual Cycle One
Comparison of PPT measurements at any two different anatomical sites showed
a large effect size for most of the comparisons (Figure 4.3). The exceptions in the tests
performed during the first menstrual cycle were the difference between anatomical sites
four and five, four and six, five and six, and seven and nine. Comparison of PPT
recorded at anatomical site four (medial fat pad of knee joint) and anatomical site five
(suboccipital muscle insertion) showed a moderate effect size, as did comparison of
sites five and six (upper border of trapezius muscle). The difference in PPT at sites four
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and six showed only a small effect size as did comparison of sites seven (origin of
supraspinatus muscle) and nine (greater trochanteric prominence of femur). All these
results are shown in Table 4.6.
Menstrual Cycle Two
The majority of PPTs recorded in the second menstrual cycle also showed large
effect sizes when comparing anatomical sites (Figure 4.3). However there were also
some exceptions. Anatomical sites two (costochondral junction of second rib) and five
(suboccipital muscle insertion) showed a moderate effect size when PPTs were
compared, as did anatomical sites seven (origin of supraspinatus muscle) and eight
(upper outer quadrant of gluteal muscles). A small effect size was found between
anatomical sites four (medial fat pad of the knee joint) and six (upper border of
trapezius muscle) and between sites seven and nine (greater trochanteric prominence of
femur). Only a trivial effect size was found between anatomical sites eight and nine.
All these results are shown in Table 4.7.
Figure 4.3: Comparison of pressure pain threshold at nine anatomical sites
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Table 4.6: Comparison of pressure pain threshold at nine different anatomical sites in the first menstrual cycle tested
Anatomical Site
1 2 3 4 5 6 7 8 9
1
1.77
(0.8 to 2.7)
1.82
(1.3 to 2.3)
1.79
(1 to 2.6)
1.81
(1.1 to 2.5)
1.80
(1.1 to 2.5)
1.81
(1.1 to 2.5)
1.81
(0.8 to 2.8)
1.81
(1.1 to 2.5)
2
1.77
(0.8 to 2.7)
1.81
(1.2 to 2.4)
1.48
(0 to 3)
1.44
(-0.1 to 3)
1.56
(0.2 to 2.9)
1.77
(0.8 to 2.7)
1.75
(0.8 to 2.7)
1.76
(0.8 to 2.7)
3
1.82
(1.3 to 2.3)
1.81
(1.2 to 2.4)
1.81
(1.2 to 2.4)
1.82
(1.2 to 2.4)
1.81
(1.2 to 2.4)
1.75
(0.8 to 2.7)
1.80
(1.1 to 2.5)
1.75
(0.8 to2.7)
4
1.79
(1 to 2.6)
1.48
(0 to 3)
1.81
(1.2 to 2.4)
0.70
(-1.3 to 2.7)
0.22
(-1.7 to 2.1)
1.72
(0.6 to 2.8)
1.65
(0.5 to 2.8)
1.71
(0.6 to 2.8)
5
1.81
(1.1 to 2.5)
1.44
(-0.1 to 3)
1.82
(1.2 to 2.4)
0.70
(-1.3 to 2.7)
1.0
(-0.9 to 2.9)
1.76
(0.8 to 2.7)
1.74
(0.7 to 2.7)
1.75
(0.7 to 2.7)
6
1.80
(1.1 to 2.5)
1.56
(0.2 to 2.9)
1.81
(1.2 to 2.4)
0.22
(-1.7 to 2.1)
1.0
(-0.9 to 2.9)
1.72
(0.6 to 2.8)
1.67
(0.5 to 2.8)
1.71
(0.6 to 2.8)
7
1.81
(1.1 to 2.5)
1.77
(0.8 to 2.7)
1.75
(0.8 to 2.7)
1.72
(0.6 to 2.8)
1.76
(0.8 to 2.7)
1.72
(0.6 to 2.8)
1.38
(-0.2 to 3)
0.2
(-1.5 to 1.9)
8
1.81
(0.8 to 2.8)
1.75
(0.8 to 2.7)
1.80
(1.1 to 2.5)
1.65
(0.5 to 2.8)
1.74
(0.7 to 2.7)
1.67
(0.5 to 2.8)
1.38
(-0.2 to 3)
1.31
(-0.3 to 2.9)
9
1.81
(1.1 to 2.5)
1.76
(0.8 to 2.7)
1.75
(0.8 to 2.7)
1.71
(0.6 to 2.8)
1.75
(0.7 to 2.7)
1.71
(0.6 to 2.8)
0.2
(-1.5 to 1.9)
1.31
(-0.3 to 2.9)
The values presented are effect sizes.
The values in brackets are lower and upper 95% confidence limits.
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Table 4.7: Comparison of pressure pain threshold at nine different anatomical sites in the second menstrual cycle tested
Anatomical Site 1 2 3 4 5 6 7 8 9
1 1.82
(1.3 to 2.3)
1.83
(1.5 to 2.1)
1.82
(1.2 to 2.4)
1.81
(1.2 to 2.5)
1.82
(1.2 to 2.4)
1.82
(1.4 to 2.2)
1.82
(1.2 to 2.4)
1.81
(1.1 to 2.5)
2 1.82
(1.3 to 2.3)
1.83
(1.5 to 2.1)
1.74
(0.7 to 2.8)
0.68
(-1.3 to 2.7)
1.72
(0.7 to 2.8)
1.82
(1.3 to 2.3)
1.71
(1 to 2.4)
1.76
(0.8 to 2.7)
3 1.83
(1.5 to 2.1)
1.83
(1.5 to 2.1)
1.82
(1.3 to 2.2)
1.82
(1.3 to 2.2)
1.82
(1.3 to 2.2)
1.82
(1.2 to 2.3)
1.79
(1 to 2.6)
1.73
(0.7 to 2.8)
4 1.82
(1.2 to 2.4)
1.74
(0.7 to 2.8)
1.82
(1.3 to 2.2)
1.64
(0.4 to 2.9)
0.59
(-1.5 to 2.7)
1.80
(1.1 to 2.5)
1.74
(0.7 to 2.8)
1.68
(0.5 to 2.9)
5 1.81
(1.2 to 2.5)
0.68
(-1.3 to 2.7)
1.82
(1.3 to 2.2)
1.64
(0.4 to 2.9)
1.60
(0.3 to 2.9)
1.81
(1.2 to 2.4)
1.78
(0.9 to 2.6)
1.75
(0.7 to 2.8)
6 1.82
(1.2 to 2.4)
1.72
(0.7 to 2.8)
1.82
(1.3 to 2.2)
0.59
(-1.5 to 2.7)
1.60
(0.3 to 2.9)
1.81
(1.1 to 2.5)
1.75
(0.8 to 2.7)
1.70
(0.6 to 2.8)
7 1.82
(1.4 to 2.2)
1.82
(1.3 to 2.3)
1.82
(1.2 to 2.3)
1.80
(1.1 to 2.5)
1.81
(1.2 to 2.4)
1.81
(1.1 to 2.5)
0.96
(-0.9 to 2.8)
0.54
(-1.5 to 2.6)
8 1.82
(1.2 to 2.4)
1.71
(1 to 2.4)
1.79
(1 to 2.6)
1.74
(0.7 to 2.8)
1.78
(0.9 to 2.6)
1.75
(0.8 to 2.7)
0.96
(-0.9 to 2.8)
0.18
(-1.9 to 2.2)
9 1.81
(1.1 to 2.5)
1.76
(0.8 to 2.7)
1.73
(0.7 to 2.8)
1.68
(0.5 to 2.9)
1.75
(0.7 to 2.8)
1.70
(0.6 to 2.8)
0.54
(-1.5 to 2.6)
0.18
(-1.9 to 2.2)
The values presented are effect sizes.
The values in brackets are lower and upper 95% confidence limits.
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DISCUSSION
The current study has added another perspective to the growing body of
literature investigating changes in pain threshold during the menstrual cycle. The
results are discussed with reference to previous research on this topic. Limitations of
the current study and future directions for research on this topic are also discussed.
In the current study trivial and small differences were found when comparing
PPTs recorded during different phases of the menstrual cycle and when examining the
difference between PPTs recorded on left and right sides of the body. The greatest
variability of PPT was found when comparing the nine anatomical sites where pressure
was applied.
Menstrual cycle
Comparison of the three test sessions within each menstrual cycle showed only a
small or trivial difference in mean PPT. The biggest difference was found between the
tests performed in the menstrual phase (approximately day 3 of the menstrual cycle) and
the luteal phase (approximately day 21 of the menstrual cycle). In both months the
effect sizes showed a small difference between these phases (Table 4.1). The menstrual
phase showed the lowest mean PPT in month one and two and the luteal phase showed
the highest mean PPT in consecutive cycles (Figure 4.1). This finding is in agreement
with Giamberadino et al. (1997) who found that the highest threshold values always
occurred in the luteal phase (days 17-22) and the lowest threshold values
perimenstrually (they defined a premenstrual phase days 25-28 but no perimenstrual
phase). Higher thresholds in the luteal phase may reflect the high levels of progesterone
present. Progesterone has a known sedative-like effect on the nervous system
(Giamberardino et al., 1997).
The results of the current study are in contrast to those reported by Drobek et al.
(2002). They found that the PPT of the temporalis muscle in the menstrual phase (days
not defined) was significantly higher, (p = 0.0408), than the follicular phase (days 5-12)
in a group of participants who were taking oral contraceptives. In the current study only
trivial differences were found between the menstrual and follicular phases and between
the follicular and luteal phases. This finding is in agreement with Isselee et al. (2001)
who found insignificant differences between the follicular and luteal phases (p =
0.2872, p = 0.1857 and p = 0.1566 for measurements 1, 2 and 3 respectively). Other
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studies have also reported no cycle related effects for PPT (Amodie & Nelson-Grey,
1989; Hapidou & Rollman, 1998).
The results of the current study showed a general trend of increasing PPTs over
the six test sessions performed during two consecutive menstrual cycles (Figure 4.1).
This trend may be a result of habituation. Habituation is a decrease in the strength of a
response after repeated presentation of the stimulus that elicits the response. Any
elicited response can exhibit habituation but it is most evident in the body’s automatic
responses to new and sudden stimuli (Mazur, 1998). Habituation proceeds more rapidly
with weak stimuli. The stimulus in the current study was pressure applied with an
algometer; the pressure was only applied until the participant felt the sensation of
pressure change to pain. This procedure may be considered to result in a relatively
weak stimulus that may increase the likelihood of habituation to the pressure being
applied. Isselee et al. (2001) reported no adaptation to their experimental stimulus.
However other studies have reported an increase in PPT over weekly sessions (Jensen,
Anderson, Olesen, & Lindblom, 1986), and testing nine to twelve weeks after a
previous experimental session (Kosek, Ekholm, & Nordemar, 1993).
Small differences were found between PPTs recorded at the same time of the
menstrual cycle over two consecutive months. This result may be due to habituation as
discussed above. It may also be due to external influences that could affect pain
sensitivity such as psychological and emotional states. Another explanation for these
small differences may be discrepancies in experimental testing times. Testing sessions
in the same phase of the menstrual cycle in consecutive months were not always
performed on exactly the same day. Testing sessions also varied as to what time of the
day they took place depending on what time was most convenient for the participant and
the researcher. All of these factors could have had some influence on how sensitive
each participant was to the pressure applied on any given day.
Anatomical sites
Comparison of PPTs taken from anatomical sites on the left and right side of the
body showed the smallest difference in PPT of all comparisons made; all effect sizes
were trivial. Drobek et al. (2002) found that the average PPTs of the masseter muscle
were higher on the right in those not taking oral contraceptives, than on the left in the
menstrual and follicular phases. In the luteal phase the average results were higher on
the left than the right for those not taking oral contraceptives, and for all phases in the
participants taking oral contraceptives. In contrast, when testing the temporalis muscle
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the same study reported that the PPT of women taking oral contraceptives was
significantly higher on the right in all phases. The current study tested sites all over the
body so when averaged there was very little difference in PPT between anatomical sites.
Perhaps if smaller anatomical areas or individual muscles were examined there would
be a clear difference between left and right.
Comparison of the nine different anatomical sites where pressure was applied
showed the biggest difference in PPT of all the comparisons made. The effect sizes
calculated showed large differences in PPT between most of the anatomical sites. There
were some exceptions of note. Anatomical sites four (medial fat pad of knee joint) and
six (upper border of trapezius muscle) were found to have only a small difference in
PPT in both month one and two as did anatomical sites seven (origin of supraspinatus
muscle) and nine (greater trochanteric prominence of femur). Both of these pairs have
one point over a muscle and one point over a relatively bony area. This finding may
indicate the type of tissue over which pressure was applied is not the key in determining
the sensitivity of the area. Giamberardino et al. (1997) found that absolute overall pain
threshold values of skin, subcutaneous and muscle tissues did not differ significantly
across the four sites that they tested. These sites were on the left and right abdomen, the
deltoid muscle of one arm and the quadriceps muscle of one leg. They also reported
that the pain thresholds were generally highest when testing muscle tissue and lowest
when testing skin. Menstrual variations in skin thresholds differed from those of
subcutaneous and muscle tissues. In the current study it was found that applying
pressure over different muscles yielded different results. Anatomical point one was the
most sensitive, this point is over the anterior scalene and sternocleidomastoid muscles.
This sensitivity is in contrast to anatomical sites seven and eight that showed two of the
highest thresholds, these were over the origin of the supraspinatus muscle and the upper
outer quadrant of the gluteal muscles respectively. The variation in thresholds over the
different muscles in the current study could be due to the area of the muscle over which
pressure is applied. For example the sites on the supraspinatus and gluteal muscles
were at the edges of the muscle bulk, if pressure had been applied to the belly of the
muscle it may have shown much more sensitivity, yielding a lower PPT. Another factor
that must be taken into consideration is the tissues and structures overlying the muscles.
The anterior cervical site has much less subcutaneous fat than the gluteal and
supraspinatus areas and many more fragile structures such as blood vessels and nerves
(Kosek et al., 1993). Iseelee et al. (2001) found similar patterns of pain sensitivity for
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the masseter, temporalis and thumb muscles. They reported that these results suggest a
generalized menstrual cycle effect on the central nervous system.
Anatomical point three showed the highest PPT. This point was two centimetres
inferior to the lateral epicondyle of the humerus. In the present study the two
centimetres was measured by the researcher using two finger widths, the tip of the
algometer was placed where the second finger lay. In hindsight it is likely that the
algometer should have been placed next to, rather than under, the second finger. This
location would be directly over the belly of the brachioradialis muscle which is very
sensitive to pressure (Kosek et al., 1993). Pressure was instead applied over the much
less sensitive common extensor tendon resulting in the highest PPTs recorded (Figure
4.3).
Relevance to fibromyalgia
The criteria for the diagnosis of fibromyalgia were designed to identify this
syndrome from other rheumatic conditions. Sleep disturbance, fatigue, and stiffness are
the central symptoms; each is present in more than 75% of fibromyalgia patients. The
criteria are widespread pain in combination with pain at 11 or more of the 18 specific
anatomical sites. These sites are digitally palpated with an approximate force of 4 kg.
Widespread pain is classified as pain on the left and right side of the body, above and
below the waist, and in the axial skeleton (Wolfe et al., 1990).
Anderberg et al. (1998) found variation in symptoms such as pain, fatigue and
depression, over the menstrual cycle in healthy individuals and those suffering from
fibromyalgia. They demonstrated that the hormonal changes over the menstrual cycle
could aggravate pain in fibromyalgia sufferers. The results of the current study showed
only small variations in the PPT over the menstrual cycle. However the raw data for the
current study (Appendix H) show that 10 of the 11 participants fitted one of the criteria
for fibromyalgia; that is that they had pain at 11 or more of the 18 anatomical sites at
4kg of pressure or less. Six of these participants fitted the criteria in all of the six
experimental sessions, one participant only in five experimental sessions and two
participants only in one experimental session. Only one participant in the current study
had less than 11 sites tender at 4kg of pressure over all six experimental sessions. This
finding shows there is variation in healthy individual’s sensitivity to pain irrespective of
the stage of the menstrual cycle they are in. Therefore hormonal fluctuations over the
menstrual cycle and individual variation in pain sensitivity are likely to influence the
diagnosis of fibromyalgia. This information should certainly be considered when
30
making the diagnosis of fibromyalgia. It will ultimately be the combination of other
criteria, such as widespread pain, fatigue, sleep disturbance and stiffness that will
discriminate patients who have fibromyalgia from those who do not.
Limitations
In the current study experimental testing times were based on an estimate of the
phase of the cycle each participant was in. The estimate was gained by recording the
participant’s menses for two months before experimental sessions began and continuing
to record menses during the two months of experimental sessions. There were many
things that could lead to an alteration of experimental testing times, such as
unavailability of the participant due to other commitments or the timing of the day
estimated coinciding with the weekend when the Osteopathic Clinic was closed. Even
if each participant could be tested on the exact day estimated throughout the two months
there is no way of knowing if the estimate was correct. Only a small percentage of
women ovulate exactly 14 days before the onset of menses, even women with regular
28 day cycles. The day of ovulation varies from day 10 of the menstrual cycle through
to day 22 (Wilcox, Dunson, & Baird, 2000). About 20% of menstrual cycles are non-
ovulatory and do not have the oestrogen and luteinizing hormone peak at ovulation
(Bajaj et al., 2002). The current study did not use any precise measures of hormonal or
ovulation status such as blood or urine testing. This lack of precise measures combined
with the unpredictability of ovulation make it impossible to know exactly what stage of
the menstrual cycle each participant was in when tested and therefore what level of key
reproductive hormones were being secreted at the time.
The current study had a small sample size of 11 participants. The restrictive
inclusion criteria, particularly the requirement that participants were not taking any oral
or injectable contraceptives, appeared to be the main factor that limited the number of
participants recruited. The small sample size limits the generalizability of the results
and an accurate estimation of the likely true values of the comparative differences. For
example the width of some of the confidence intervals (Table 4.6 and 4.7) extend
beyond adjacent qualifiers for the estimated true values.
None of the anatomical sites tested in the current study were in the suggested
areas of referral for menstrual pain, namely the abdomen (T10-T12) and low back (S2-
S4) (Bajaj et al., 2001). These areas have demonstrated more prominent cyclical
variation in PPT (Giamberardino et al., 1997). Although systemic effects have also
been demonstrated (Bajaj et al., 2001; Isselee et al., 2001), the particular anatomical
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areas outlined above may offer a window into the variation in pain threshold due to the
fluctuation of hormones over the menstrual cycle.
Conclusion
The results of previous research show that pain sensitivity is certainly influenced
by hormonal changes over the menstrual cycle. The current study adds to this evidence
and also shows individual variation in pain sensitivity regardless of the menstrual cycle.
The results of the current study showed small differences in PPT between the menstrual
and luteal phases of the menstrual cycle, with the luteal phase showing the highest mean
pain threshold and the menstrual phase showing the lowest in consecutive months. A
general trend of increasing pain thresholds over the six experimental sessions was also
shown. The largest differences in PPT were found when comparing the nine different
anatomical sites where pressure was applied. Many of the participants in the current
study found 4kg of pressure painful at 11 or more of the 18 anatomical sites. This
finding adds to the literature surrounding the diagnosis of fibromyalgia and indicates
that not only menstrual cycle variations in pain threshold but also individual variation
should be considered when making a diagnosis of fibromyalgia.
Osteopaths and other health professionals should be aware that women may be
more sensitive to pain at different times of the menstrual cycle, particularly the
menstrual phase according to the results of the current study. They should also keep in
mind that different individuals have different pain thresholds and may respond
differently to pressure applied in exactly the same way. The results of the current study
suggest that patients of any manual therapist are likely to be more sensitive to sensations
evoked on the first appointment than they will be in follow up sessions when
habituation may occur.
There are many studies that report results in agreement with each of these
findings; there are also many studies that report contrasting results. Diversity in
methodology is the main area of discrepancy among the literature surrounding this
topic. In particular the definition of the phases of the menstrual cycle, the method of
stimulation used to induce pain, and the sites at which stimulation is applied. Future
research on this topic should aim for unity between all of these factors in order to
achieve results that can be directly compared. The current study may serve as the
beginning of an ongoing investigation of the changes in PPT due to normal hormonal
fluctuations during the menstrual cycle. The methods used can form a template for
future research and the results can be used in meta-analysis of this topic.
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ETHICS APPROVAL
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Appendix B
ADVERTISING POSTER
I am interested in finding out if your perception of pressure 
changes over a month. 
 
I am seeking New Zealand European females, aged 18 to 35, 
who are not taking oral or injectable contraceptives. 
 
Your participation will help us establish if women are more 
sensitive to manual therapies at certain times during the 
menstrual cycle.  
Please contact me if you are interested! 
 
Alenka Dunnett 
Master of Osteopathy student 
815 3265 
021 1124137 
alenkadunnett@hotmail.com
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Appendix C
PARTICIPANT HEALTH HISTORY
AN INVESTIGATION OF CHANGES IN PRESSURE PAIN THRESHOLD DUE TO HORMONAL
FLUCTUATIONS DURING THE MENSTRUAL CYCLE
Researcher: Alenka Dunnett
Please answer the following questions in the spaces provided, please answer to the best of your ability,
please print legibly and please do not hesitate to ask questions if you do not understand a question.
Participant number: ________________________
Date of birth: ______________________________
Age: ______________________________
Are you currently taking any medication or health supplements? Yes/No
If yes please record here: ________________________________________________
If you have any of the following health problems please circle:
Dysmenorrhoea (difficult and painful menstrual period)
Arthritis
Fibromyalgia
Nausea
Vomiting
Chronic pain problems
Epilepsy
Heart disease
Psychological health problems (depression, anxiety, other)
List any other health problems you suffer from: _______________________________
______________________________________________________________________
How many hours of sleep do you get a night? _________________________________
How would you describe your general health? _________________________________
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Appendix D
HEALTH HISTORY FOLLOW-UP QUESTIONNAIRE
Participant #:
Health
History
Follow Up
Oral
contraceptives?
Analgesics? Any other
medication?
Dysmenorrh
-oea?
Other illnesses?
Experimental
Session
#1
#2
#3
#4
#5
#6
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Appendix E
PARTICIPANT INFORMATION SHEET
AN INVESTIGATION OF CHANGES IN PRESSURE PAIN THRESHOLD DUE TO HORMONAL
FLUCTUATIONS DURING THE MENSTRUAL CYCLE
IMPORTANCE OF THE STUDY
A large percentage of osteopathic patients have musculoskeletal pain as their chief
complaint. Musculoskeletal pain is due to a variety of causes. One factor influencing
the experience of pain may be hormonal fluctuations during the menstrual cycle. The
effect of hormonal changes on pain sensitivity has particular relevance to the practice of
osteopathy. The techniques used by an osteopath may generate pain. The female
patient may be more sensitive to pain at certain times of the menstrual cycle.
SELECTION OF PARTICIPANTS AND CRITERIA FOR INVOLVEMENT
New Zealand European female students at Unitec New Zealand are invited to take part
in this study. If you are aged between the 18 and 35 years, and are able to communicate
clearly using oral and written English language you are welcome to participate. You
must have a history of regular, predictable menstrual cycles of 25-30 days and must not
be taking oral or injectable contraceptives. In order to ensure this, you will be asked to
inform the researcher of the first and last day of menstrual period for two months (two
cycles) before the experiment begins.
REGISTRATION
Participants interested in volunteering for the study can register their interest by
telephoning the researcher, Alenka Dunnett, at 815-3265 or 021 1124137. You will be
asked a few questions to be sure you fulfil the criteria for involvement.
EXPERIMENTAL SESSIONS
Before the commencement of the testing sessions you will be required to answer some
questions relating to your general health and relevant medical history. You will need to
answer follow up questions before each testing session to ensure there are no major
changes in your health status over the course of the study.
The experiment involves applying pressure to eighteen anatomical sites on the body
until the sensation of pressure changes to pain. You will be required to verbally indicate
when this occurs and the pressure will be removed immediately. There will be a chance
for you to see exactly what the experiment involves before you agree to participate.
You will be asked to attend six testing sessions at the Unitec Osteopathic Clinic, over a
period of eight weeks. You will be asked to record the first and last day of your
menstrual period from approximately April 2005 to May 2005 and to attend
experimental sessions from approximately June 2005 to July 2005. You will be
required to wear shorts and a t-shirt for the experimental session; changing rooms will
be provided. The experimental session will take approximately fifteen minuets. Please
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call if you are running late or need to reschedule the appointment on the following
numbers: 8156794 (clinic) or 021 1124137 (Alenka Dunnett).
CONFIDENTIALITY
I will ask that you do not write your name anywhere on the health history sheet. This is
important to protect your anonymity. There are numbers on these sheets so that I can
correlate these anonymous results with your anonymous experimental results. A copy
of the final results will be available at the School of Health and Community Studies,
Unitec New Zealand. All participants are welcome to view this.
WITHDRAWAL FROM THE STUDY
Your participation in the study is voluntary so you may withdraw at any time.
FOR MORE INFORMATION CONTACT THE RESEARCHER:
Alenka Dunnett, Master of Osteopathy Student
Phone: 09 815 3265 or 021 1124137
Email: dunnea01@studentmail.unitec.ac.nz
PRIMARY SUPERVISOR:
Dr Dianne Roy
Phone: 09 815 4321 ext 8307
Email: droy@unitec.ac.nz
SECONDARY SUPERVISORS:
Dr Andrew Stewart
Phone: 09 815 4321 ext 8384
Email: astewart@unitec.ac.nz
Dr John McPartland
Email: jmcpartland@unitec.ac.nz
Thank you for your valuable contribution to this research.
This study has been approved by the Unitec Research Ethics Committee from February
2005 to July 2005. If you have any complaints or reservations about the ethical conduct
of this research, you may contact the Committee through the Secretary (ph: 815-4321
ext 8041, or ethics@unitec.ac.nz). Any issues you raise will be treated in confidence
and investigated fully, and you will be informed of the outcome.
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Appendix F
CONSENT FORM
AN INVESTIGATION OF CHANGES IN PRESSURE PAIN THRESHOLD DUE TO HORMONAL
FLUCTUATIONS DURING THE MENSTRUAL CYCLE
Thank you for agreeing to participate in this research.
My name is Alenka Dunnett and I will be conducting the research. I will be examining
changes in the pressure pain threshold due to hormonal fluctuations during the
menstrual cycle. I am interested in the effect of variations in pressure pain threshold on
osteopathic treatment and osteopathic diagnosis. Dr Dianne Roy, Dr John McPartland,
and Dr Andrew Stewart are supervising this research project.
Name of participant (please print) …………………………………………………..
I have read and understood the contents of the information sheet. I have had the
opportunity to discuss with the researcher anything I was unclear about, and I have
understood the explanations given. I understand that my involvement with this research
is voluntary and that I have the right to withdraw at any time up until the data analysis is
complete in approximately July 2005. I understand that my participation in this project
is confidential and that no material that could identify me will be used in any reports on
this project. I have had enough time to consider whether I want to take part. I know
whom to contact if I have any questions or concerns about the project.
Signature of participant ……………………………….... Date ….…………………..
Project explained by …………………………………….
Signature of researcher …………………………………. Date ……………………..
The contact details of the principle researcher for this project are:
Alenka Dunnett
Osteopathic Clinic
Building 41, Entry 3
Unitec New Zealand
Carrington Rd, Mt Albert Telephone (09) 815 6794
Private Bag 92025 Free phone 0800 267 836
AUCKLAND A/H (09) 815 3265 or 021 1124137
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The participant will be given two copies of the consent form to sign and should retain
one and return one to the researcher. This study has been approved by the Research
Ethics Committee from February 2005 to July 2005. If you have any complaints or
reservations about the ethical conduct of this research, you may contact the Committee
through the Secretary (ph: 815-4321 ext 8041, or ethics@unitec.ac.nz). Any issues you
raise will be treated in confidence and investigated fully, and you will be informed of
the outcome.
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Appendix G
ANALYSIS OF DATA WITH PARTICIPANT NINE REMOVED
Table 6.1: Intra-cycle Test Point Comparison
Comparison Effect Size Lower 95%
Confidence Limit
Upper 95%
Confidence Limit
Interpretation
Test 1 & 2 0.1 -0.9 1.1 Trivial
Test 1 & 3 0.2 -0.8 1.2 Small
Test 2 & 3 0.2 -0.9 1.2 Small
Test 4 & 5 0.01 -1.2 1.2 Trivial
Test 4 & 6 0.2 -0.8 1.2 Small
Test 5 & 6 0.2 -0.7 1.1 Small
Table 6.2: Inter-cycle Test Point Comparison Showing Effect Sizes
Comparison Effect Size Lower 95%
Confidence Limit
Upper 95%
Confidence Limit
Interpretation
Test 1 & 4 0.4 -0.6 1.3 Small
Test 2 & 5 0.3 -0.7 1.3 Small
Test 3 & 6 0.3 -0.7 1.4 Small
Table 6.3: Inter-cycle Test Point Comparison Showing Effect Statistics
Comparison Effect Statistic (kg) Lower 95%
Confidence Limit
Upper 95%
Confidence Limit
Test 1 & 4 0.4 -0.6 1.4
Test 2 & 5 0.3 -0.7 1.3
Test 3 & 6 0.3 -0.7 1.3
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Table 6.4: Comparison of Change Scores between Pares of Tests in Consecutive
Months
Comparison Effect Size Lower 95%
Confidence Limit
Upper 95%
Confidence Limit
Test 1& 2 v test 4 & 5 0.1 -0.2 0.4
Test 2 &3 v test 5 & 6 0.2 0 0.4
Test 1 &3 v test 4 & 6 0.2 -0.1 0.5
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Appendix H
RAW DATA
Table 6.5: Pressure pain thresholds for all 11 participants shown in raw kg values. The
18 values in each test are arranged from anatomical sites one to nine alternating left and
right, for example the first two numbers in each column are anatomical site one, the first
is the left site and the second is the right site.
Participant Test 1 Test 2 Test 3 Test 4 Test 5 Test 6
1 2 1.75 1.8 1.6 2.5 2.1
2 1.3 1.65 1.5 1.6 1.75
3.9 2.5 3.8 3.75 4.3 3.7
5 3 2.7 2.55 2.7 3.05
5.5 7.7 8.2 10.5 8.4 8.85
10.5 6.3 7 10.5 10.5 7.2
2.4 4.4 2.8 5.3 2.85 4.75
3.6 4 4 4.45 2.9 4.7
6.6 4.9 3.4 4.1 4 5.1
6 3.95 3 4.6 3.3 5.65
3.4 5.95 3.45 5 5.75 5.6
3.85 5.4 2.9 5.1 4 5.5
6.7 5.85 4.4 6.35 6.4 7.1
5.5 6.1 6.7 6.6 6.1 5.3
3.1 3 3.4 4 4.25 4.05
3.95 3.8 3.1 3.9 5.5 4.5
3.1 5.4 3.2 3.85 3.8 4.15
4.25 5.9 3.9 3.45 4.35 8.9
2 1.2 1.2 2.45 1.95 1.85 3
1.15 0.5 2.5 1.7 1.7 1.9
3 3.65 4.4 4.4 4.4 3.2
2.2 2.6 5 4.2 3 2.9
9.8 8.7 10.5 10.5 10.5 10.5
9.4 6.75 9.75 8 10.5 10.5
2.85 3 4.1 4 4.9 4.1
4 5.3 6.8 4.8 5 4.8
3.7 4.85 5 4.25 3.8 5.7
3.6 6.3 6.7 5.2 4.05 4.4
4.8 4.9 5.4 5.25 6 6.2
3.75 5.65 7.15 5.7 7 4.9
6.75 6.7 8.2 7.9 5.5 6.3
5.6 8.8 7.85 6.35 7.1 5.7
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3 4.75 3.2 5.6 4.25 4.3
2.4 3.6 3.05 5.15 4.2 4.4
2.4 7 7.9 5.9 5.3 4.6
2.7 7 6.7 5.5 5.3 5.3
3 1.3 1.6 1.5 1.2 1.45 1.4
1.3 1.2 1.4 1.2 1 1.3
2.2 1.8 2.4 1.9 2.4 3
2.8 2.25 2.85 2.2 2.8 3.4
5.45 3 4 4 4.8 5.9
3.75 4.65 4.4 4.6 4.95 5.9
2.15 1.95 2.9 3.25 3.2 3.1
2.25 2.3 2.9 2.05 2.9 2.5
3.5 1.85 2.6 2.2 2.6 2.8
2.9 2.2 2.2 2.1 2.4 2.25
2.85 3 3.7 3.9 3.25 3.95
3.8 3.15 3.9 4.2 3.4 3.25
3.35 3.55 3.8 3.3 3.55 3.4
3.35 3.4 4.1 4.35 4 5.35
2.6 3 3.1 2.15 4.05 3.3
4.2 3.6 3.75 3.55 3.45 4.1
3 3.1 3.4 2.4 3.15 4.3
3.6 3 3.9 3.4 3.6 3.25
4 0.5 0.5 1.1 1.1 1 0.5
1.1 0.5 0.5 0.5 0.5 1
1.3 2.75 3.2 2 1.75 2.9
1.9 1.65 1.9 2.3 1.4 2.8
6 3.7 5.7 6 4.7 5.2
4.8 4 3.8 6.35 5.15 4.7
2.2 2.1 1.7 2.4 2.3 2.1
2.6 2.1 2.3 2 1.8 3.3
2 1.9 2.2 2.35 1.8 2.7
1.9 1.75 2.2 1.4 1.6 2
1.7 2 1.6 2.5 1.8 1.9
1.8 2.2 2.45 2 2.5 1.6
2.8 2.3 3.45 2.6 3.9 4
3.1 2.5 2.5 2.4 2.9 3.5
2.75 2.6 2.2 2.5 3 2.8
2.5 2.1 1.7 2.4 3 3.05
3.1 2.9 3.2 4.6 3.4 6.4
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3.35 3.6 5.2 4.2 2.8 4.1
5 0.5 1 1 1.7 0.5 1
1 1 0.5 1.8 1 1.15
1.25 2.4 1.7 2.2 2.85 2.8
1.8 2.65 1.9 2.55 2.8 2.45
4.9 4.7 4.3 4.7 5.1 3.9
6.6 5.3 4.1 3.9 4.7 3.1
3.2 3 3.3 3.7 3.1 3.85
2.55 2.65 3.9 3.9 2.9 3.85
3 2.8 1.9 2.7 2.6 2.2
4.3 1.75 2.15 2 2 2.1
2.6 1.8 2.65 2.1 1.7 2.9
2.6 2.2 3 2.1 1.6 2.2
3 4 3.6 3.3 3.45 3.6
3.6 3.4 2.6 2.8 3.1 4.85
3.7 2.95 4.6 4.6 4.85 3.9
4.6 3.35 3.95 4.7 6.4 4.45
5.35 5.25 6.2 6.2 7.1 6.55
5.7 6.4 4.2 3.8 4.5 5.59
6 0.5 0.5 0.5 1.1 1.15 3.2
0.5 0.5 1 1 1 1
1.5 1.9 2.4 3.8 3.1 3.3
1.4 1.6 2.45 2.8 2.55 3.9
1.8 2.5 2.8 5.2 2.9 4.3
1.6 3.4 3.1 3.2 4 3.45
1.4 1.7 1.6 1.6 1.9 2.6
1.4 1.45 1.8 1.5 2.1 2
1.25 1.85 1.85 2.35 1.8 2.05
0.5 1.85 2.7 2.5 2.4 2.8
1.2 3.4 1.6 5.55 4.5 2.7
1.05 2.1 1.15 4.7 1.6 2.9
1.8 2.6 2.9 5.5 3.65 3.8
1.75 2.1 2.7 4.1 3.65 4
2.25 1.8 3.1 3.2 3.1 3.5
1.9 2.4 2.15 4.4 5.1 2.6
1.9 1.9 2.2 3.2 4.1 2.75
1.7 2.8 2.7 2.9 2.55 2.55
7 1 1.05 2.3 1.5 3.7 1.8
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1.6 0.5 1.75 1.35 1.6 1.8
3.9 2.65 2.9 2.8 2.5 2.25
2 1.3 2.6 2 2.8 2.6
7.5 6.2 5.15 5.5 5 7
6 7.6 5.05 3.6 4.4 5.5
3.9 5.7 2.8 4.15 4.1 5.1
5.6 6 5.8 3.8 6.4 5.05
2.8 2.3 3.2 2.5 2.6 2.4
2.45 3.7 3 3.1 3.1 2.8
5.2 3.7 3.15 4.8 2.7 2.65
4 4.85 2.95 3 2.9 3.8
4.25 4.8 4.5 3.05 4.4 4.1
3.6 4.8 4.4 4.8 6 4.9
5.25 3.8 4.4 5 4.3 5.15
5.4 6 6 6.3 3.5 4.2
6.9 5.2 2.7 8.55 5.6 3.05
6.7 3.6 3.85 8.2 3 6.3
8 0.5 0.5 0.5 1.1 1 1.4
0.5 0.5 0.5 1.05 0.5 1.1
1.2 1.4 1.35 1.7 1.5 2.2
1.1 1.6 2.1 1.9 2.05 2
1.15 2.4 3 3 3.5 3.9
2.15 3 3 3 3.25 4.4
1.15 1.9 2.45 1.95 2.5 2.5
1.5 1.55 1.85 2.1 2.9 2.8
1.15 1.4 1.8 1.25 1.75 2.4
1.4 1.5 1.95 1.3 1.6 2.15
1.05 1.6 1.6 1.1 2 2.4
1.7 1.9 2.15 1 2.15 2.9
2.8 3.5 3.4 2.7 3.5 2.7
2.85 2.5 3.3 2.95 3.3 3.6
2.45 2.8 2.75 3.2 2.9 4.2
2.35 2.4 3.1 3.1 3.4 4
2.4 2.75 4.05 2.65 3.5 4.7
2.3 2.2 3 2.15 2.6 4.4
9 1.5 1.9 1.85 1.35 2 1.8
1.15 1.7 1.8 1.6 1.5 0.5
2.3 2.8 3.85 2.45 2.7 2.6
1.9 2.7 2.2 2.4 3 2.2
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5.2 4.55 3.8 5 5.1 4.9
3.6 3.8 3 4 3.4 3.4
3.4 3.6 3.7 4.2 4.2 3.55
3.35 4 3 3 3.6 4
3.4 2.7 4.3 3.35 4.3 3
3.1 2.85 3.35 3.6 4.05 3.4
2.4 1.85 2.3 2.9 3.6 2.8
2.35 3.1 2.1 2.8 3 1.85
4.05 3.9 3.9 4.7 4.3 4.9
1.8 3.9 3.9 5 4 5.1
4.25 5.95 4.45 6.75 6.75 5.2
4 7 3.6 6.15 6.75 6.55
3.5 3.6 4.6 3.9 6 3.5
5.05 4.85 4 5.4 4.6 4.65
10 1.85 1.25 2.5 2.35 2.5 1.9
2.25 1.9 2.6 1.9 2.1 1.85
5 3.8 4.8 4.4 5.1 3.7
3.7 3.4 2.8 3.05 3 2.5
7.65 5.95 7.1 7.6 6.2 5.85
6.3 6.75 7.3 7.75 7.1 6.8
3 3.4 3.1 4.2 4.8 3.5
3.9 3 3.1 3.5 4.9 3.1
3.5 3.5 4.3 4.8 2.6 2.15
2.5 3.1 2.9 3.7 3.1 3
4.6 4.05 5 4.7 3.4 3.8
3.9 3.7 4 4.5 3.1 2.7
3.55 4.4 3.8 6.8 6.1 6.9
3.3 3.6 4.6 4 5.2 5.25
5.25 5.2 5.75 4.25 5 5.85
4.6 4.45 4.45 3.5 5.7 4.5
4.7 4.4 5.2 3.35 4.7 5.6
4.7 4.4 5.15 3.8 4.4 7.1
11 1.9 1.6 1.5 1.1 1.2 1.55
1.35 1.1 1.25 1.35 1.2 1.6
2.1 1.95 1.8 3 2.9 3.5
2.7 2.3 2 2.8 2.5 2.3
2.7 5 4.9 3.85 4.4 4.5
4.2 3.5 4.2 3.1 4.1 4
1.9 2.5 2.6 2.9 2.4 3.2
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2.6 2.35 1.75 2 1.75 2.4
1.7 2 1.8 2.2 2.1 2.2
3.6 1.8 2.1 2.6 2.9 3
3.4 3.2 2.9 3.25 3.4 2.9
2.7 2.6 2.4 2.85 3.3 2.7
3.8 2.95 3.65 3.1 3.5 2.8
4.2 4.2 3.95 4.1 5.3 3.95
1.9 2.95 4 2.65 5.15 3.9
2.4 3.5 5.25 3.45 5.95 5.2
1.9 2.25 2.55 2.85 2.1 3.3
2.1 1.85 3 2.8 3.65 3.8
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